, , p.1
,
, , p.3
4 FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2017. ,
, Relationships between low-grade peripheral inflammation and psychotropic drugs in 6 schizophrenia: results from the national FACE-SZ cohort, Eur. Arch. Psychiatry Clin
,
,
, Prescription of potentially inappropriate psychotropic 10 drugs in homeless people with schizophrenia and bipolar disorders, p.11, 2018.
, Housing First (FHF) program, Prog. Neuropsychopharmacol. Biol. Psychiatry
,
, , p.14
, , p.15
, , p.16
FACE-SZ group, Metabolic syndrome, 17 abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02473263
, Schizophr. Res
, , p.20
, , p.21
, , p.22
23 FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2017. ,
, Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French 25 FACE-SZ cohort, J. Psychiatr. Res, vol.94, pp.62-69
,
Diagnosis and Management of the Metabolic Syndrome: An American 28, 2005. ,
, Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, vol.29, pp.2735-2752
The effect of antidepressant medication 31 treatment on serum levels of inflammatory cytokines: a meta-analysis, 2011. ,
, Neuropsychopharmacology, vol.36, pp.2452-2459
The positive and negative syndrome scale 34 (PANSS) for schizophrenia, Schizophr. Bull, vol.13, pp.261-276, 1987. ,
, , p.36
, , p.37
Peripheral cytokine and chemokine alterations in depression: a meta-38 analysis of 82 studies, Acta Psychiatr. Scand, vol.135, pp.373-387, 2017. ,
,
, , p.41
, , p.42
Peripheral Alterations in Cytokine and Chemokine Levels After 1, 2018. ,
, Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta
, Analysis. Mol. Neurobiol, vol.55, pp.4195-4206
, , p.4
Healthy dietary indices and risk of depressive outcomes: a systematic 5 review and meta-analysis of observational studies, Mol. Psychiatry, 2018. ,
,
, , vol.8
Toward a transdiagnostic tool to evaluate depressive symptoms across 9 mental disorders: Validation of the Calgary depression rating scale in patients with major 10 depressive disorder, Psychiatry Res, vol.268, pp.68-71, 2018. ,
,
, , p.13
, , p.14
, , p.15
,
, Nicotine dependence is 17 associated with depression and childhood trauma in smokers with schizophrenia: results from 18 the FACE-SZ dataset, Eur. Arch. Psychiatry Clin. Neurosci, 2017.
, , p.21, 2016.
, Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses, Am. J. 22 Psychiatry, vol.173, pp.575-587
Development 24 of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on 25, 1993. ,
, Early Detection of Persons with Harmful Alcohol Consumption--II, Addict. Abingdon Engl, vol.26, pp.791-804
, , p.28
, , p.29
, , p.30
31 FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, FondaMental Academic Center of Expertise for Schizophrenia, vol.33, p.32, 2018. ,
,
,
, Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With, vol.36, p.37, 2013.
, Schizophrenia: An Update, Schizophr. Bull. sbt139
The concurrent validity of the Global 39 Assessment of Functioning (GAF). Br, J. Clin. Psychol, vol.41, pp.417-422, 2002. ,
Prevalence of metabolic syndrome and its association with 41 depression in patients with schizophrenia, Neuropsychiatr. Dis. Treat, vol.9, pp.941-946, 2013. ,
,
,
The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: 3 A Systematic Review and Meta-Analysis of Randomized Controlled Trials, vol.81, pp.570-583, 2019. ,
Levels of C-reactive 6 protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder, 2014. ,
, J. Psychiatry, vol.1, issue.8